SIM
GTHX

Sonora Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Sonora Investment Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$17K Hold
1,250
– – ﹤0.01% 673
2021
Q2 		$27K Buy
1,250
+250
+25% +$5.55K ﹤0.01% 518
2021
Q1 		$24K Buy
+1,000
New +$23.2K ﹤0.01% 896

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sonora Investment Management's GTHX Position: Q3 2021 in Review

Sonora Investment Management held its G1 Therapeutics, Inc. Common Stock (GTHX) position steady in Q3 2021 at 1,250 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Sonora Investment Management first reported a position in GTHX in Q1 2021 and has held it in 3 quarters since. The position peaked at $27K in Q2 2021. 115 funds tracked by Wall St. Rank hold GTHX as of Q3 2021.

  • Sonora Investment Management held 1,250 shares of G1 Therapeutics, Inc. Common Stock worth $17K as of Q3 2021.
  • Sonora Investment Management left its G1 Therapeutics, Inc. Common Stock share count unchanged in Q3 2021.
  • G1 Therapeutics, Inc. Common Stock made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #673 holding.
  • Sonora Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2021 and has held it in 3 quarters since.
  • Sonora Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $27K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.